In the Finnish study, 8.4% (16 of 190) men with prostate cancer and a positive family history were positive for the HOXB13 variant, higher than observed in other cohorts of familial prostate cancer but similar to that in Sweden, suggesting a founder effect for the variant100. The gene discussed is HOXB13; the disease is prostate cancer.